Belgian registry for extravascular ICDs to track real-world use
Official title: Observational BELgian Registry of Implanted EV-ICD to Evaluate Parameters and Complications of the New Device in Real World Settings
Run by AZ Sint-Jan AV · NCT07156851 · Data updated 2026-11-12
This Belgian registry follows adults with extravascular ICDs to see how the devices perform and what issues arise over time in routine care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | AZ Sint-Jan AV Academic / other |
| Locations | 7 sites (Antwerp and 6 other locations) |
| Status | Recruiting |
| Started | September 25, 2025 |
| Main results expected | July 1, 2040 |
| Study ends | July 1, 2040 |
| Registry record updated | September 15, 2026 |
| Trial ID | NCT07156851 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who have had or will have an EV-ICD implanted and have provided informed consent.
✕Probably not a fit
Patients who do not undergo EV-ICD implantation or who do not consent may not contribute to the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The BELIEVE registry collects real-world data on extravascular ICDs (EV-ICDs) used in Belgium, focusing on device parameters, complications, arrhythmia detection and therapy, and patient outcomes. It is a multicenter observational study that combines retrospective and prospective data without altering standard care. Eligible participants include adults with current or planned EV-ICD implantation, with data gathered from medical records after informed consent. The study aims to enroll about 100 patients over four years to understand long-term performance, safety, and effectiveness of EV-ICDs in everyday practice.
Why it matters
Potential benefit: If successful, the registry could clarify long-term safety and effectiveness of EV-ICDs and inform clinical practice and device development in Belgium.
How similar studies have gone: Preliminary trials have shown feasibility and safety of EV-ICDs; real-world registries like this one help confirm and extend those findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 18 years old * Previous or planned EV-ICD implantation (successful or not) * Informed consent signed Exclusion Criteria: * Patients who did not undergo any step of the implantation procedure
Where it's running
-
Uza
Antwerp, Belgium Recruiting -
ZAS Middelheim
Antwerp, Belgium Recruiting -
AZ Sint-Jan Brugge
Bruges, Belgium Recruiting -
UCL Saint-Luc
Brussels, Belgium Recruiting -
UZ Brussel
Brussels, Belgium Recruiting -
UZ Gent
Ghent, Belgium Recruiting
Show 1 more location
-
CHU Liège
Liège, Belgium Not yet recruiting
Study contacts
- Study coordinator: Emma Christiaen
- Email: SM-SJ-Cardiologie-Studies@azsintjan.be
- Phone: +32 50 45 32 93
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Upper-extremity exercise options for people with heart failure and implanted devices
This study tests different upper-extremity exercise programs to see which helps people with heart failure and implanted defibrillators or CRT devices improve arm function.
-
Optimal ATP settings for new ICDs in heart disease patients
This trial tests whether Burst or Ramp ATP settings in the VT zone of a new ICD help patients with heart disease.
-
Carvedilol versus metoprolol succinate in people with heart failure and an implanted defibrillator
This study will test whether switching from metoprolol succinate to carvedilol reduces ICD therapies, heart-related hospitalizations, or cardiovascular death in adults with HFrEF and an ICD.
-
CHOICE-ICD: online education and support for people with an implantable cardioverter defibrillator
This project will test an online education and support program (CHOICE-ICD) for people awaiting or recently fitted with an ICD and their families to help lower anxiety and improve quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.